Skip to search formSkip to main contentSkip to account menu

CA9 protein, human

Known as: Membrane Antigen MN, Carbonic Anhydrase IX, RCC-associated antigen G250, human 
Carbonic anhydrase 9 (459 aa, ~50 kDa) is encoded by the human CA9 gene. This protein is involved in intracellular pH balance and may be involved in… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Antigens, NeoplasmCarbonic Anhydrase IX
CA9 geneEnzyme Gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Comparison of specific expression profile in two in vitro hypoxia models
The microenvironment plays a fundamental role in carcinogenesis: Acidity and hypoxia are actively involved in this process. It is… 
2016
2016
AS Lagny - RCC 78
4e match de Championnat PH demain dimanche 16 octobre au Stade du Fort du Bois a Lagny. L'equipe premiere, avec 3 victoires dont… 
2016
2016
Abstract 754: Targeting carbonic anhydrase IX in multiple pancreatic ductal adenocarcinoma models results in tumor growth inhibition and increased survival
Pancreatic ductal adenocarcinoma (PDAC) is characterized by aggressive growth, metastatic spread and poor 5 year survival rates… 
2016
2016
Abstract B25: Characterization, targeting, and modulation of carbonic anhydrase IX activity for the development of small-molecule inhibitors to treat triple-negative breast cancer
The microenvironment within a solid tumor is usually heterogeneous with certain regions being acidic and hypoxic. These acidic… 
2015
2015
MP39-05 INHIBITION OF CARBONIC ANHYDRASE IX CONFERS RADIATION SENSITIVITY TO RENAL CELL CARCINOMA
Review
2011
Review
2011
预测贝伐珠单抗抗肿瘤治疗效果的生物学标记物
贝伐珠单抗已被用于多种恶性肿瘤的治疗，但仍没有一个公认的普遍适用的疗效预测指标。目前除了以影像学、副反应作为预测因子外，很多研究集中在对生物学标记物的筛选上。循环标记物中血管内皮生长因子（vascular endothelial growth factor… 
2011
2011
Abstract 2276: Serum endoglin and uPA change predicts PFS and overall survival in first line trastuzumab-treated breast cancer
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: About half of HER2-positive breast cancer… 
2010
2010
Use of serum uPA change to predict PFS and overall survival in first-line trastuzumab-treated breast cancer.
1050 Background: About half of patients with HER2-positive breast cancer will respond to first-line trastuzumab-containing… 
2008
2008
Adjuvante Therapiestrategien beim Nierenzellkarzinom
ZusammenfassungDas Nierenzellkarzinom hat unter den urologischen Tumoren die schlechteste Prognose. Meist besteht die Prim… 
1995
1995
Transformation of Sordaria macrospora to hygromycin B resistance: characterization of transformants by electrophoretic karyotyping and tetrad analysis
The ascomycete Sordaria macrospora was transformed using different plasmid molecules containing the bacterial hygromycin B… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)